4SC AG INH. O.N./ DE000A3E5C40 /
| 15/01/2025 9:22:08 | Diferencia -0.7400 | Volumen | Bid15:17:43 | Ask15:17:43 | Capitalización de mecado | Dividendo A. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 5.0600EUR | -12.76% | 0 Volumen de negocios: 0.0000 |
5.4000Volumen de oferta: 100 | 6.3200Tamaño/ Volumen/ Formato de Ask: 80 | 51.18 millonesEUR | - | - |
GlobeNewswire
05/12/2023
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronch...
GlobeNewswire
01/04/2019
Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Respons...
GlobeNewswire
11/06/2018
Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Directory 2012-2018
